Fmoc-D-isoleucine

Fmoc-D-isoleucine is a D-configured isoleucine amino acid building block bearing an N-(9-fluorenylmethoxycarbonyl) (Fmoc) protecting group and a free carboxylic acid, providing a stable, base-labile handle for stepwise peptide assembly. The molecule retains the chiral α-carbon stereocenter of D-isoleucine and presents a hydrophobic, branched side chain with an aliphatic isopropyl-like motif that influences conformational preferences in peptides and peptidomimetics. The Fmoc carbamate masks the amino functionality during coupling, while the carboxylic acid can be activated for amide bond formation under standard peptide coupling conditions. The combination of stereochemistry, protected amine, and reactive acid makes Fmoc-D-isoleucine a practical chiral intermediate for constructing D-amino acid segments, including unnatural amino acid incorporation and downstream functionalization of peptide scaffolds.

1. Peptide Synthesis

Fmoc-D-isoleucine is used in solid-phase peptide synthesis and solution-phase peptide assembly where D-amino acid incorporation is required for protease resistance and altered secondary-structure behavior. The Fmoc-protected amine enables controlled deprotection and subsequent coupling, while the free carboxylic acid participates in peptide bond formation to install a D-isoleucine residue at a defined position. The D stereochemistry is preserved through the coupling step, supporting stereochemically consistent peptide building block preparation for library synthesis and sequence-specific studies. The resulting D-isoleucine-containing peptides can serve as substrates, standards, or scaffold variants in peptide chemistry and chemical biology workflows.

2. Chiral Amino Acid Intermediate

Fmoc-D-isoleucine functions as a chiral amino acid intermediate for stereoselective synthesis routes that require a D-configured α-amino acid unit. The protected carbamate (Fmoc) and carboxylic acid allow orthogonal handling: Fmoc can be removed under basic conditions to reveal the amine for further transformations, while the acid can be converted to activated esters or amide-forming derivatives as needed. The branched isoleucine side chain provides a hydrophobic element that can influence coupling selectivity and downstream conformational outcomes in peptidomimetic frameworks. The compound can be employed to prepare additional protected amino acid derivatives and chiral fragments used in fine chemical synthesis and process development.

3. Peptidomimetics And SAR Studies

Fmoc-D-isoleucine is applied in peptidomimetic construction and structure-activity relationship studies where D-amino acid substitution is used to tune binding-site interactions and metabolic stability of peptide-like molecules. The Fmoc group supports incorporation into longer sequences, while the D-isoleucine residue provides a stereochemically defined hydrophobic side chain that can modulate local folding, turn propensity, and side-chain packing. The ability to introduce a single D residue at a controlled position enables systematic analog generation for SAR workflows, including sequence scrambling and D/L scanning strategies. The resulting D-amino acid-containing analogs can then be used as reference compounds for analytical method development and comparative scaffold evaluation in medicinal chemistry research.

4. Protein Engineering

Fmoc-D-isoleucine can be utilized in protein engineering and chemical protein modification contexts that require site-specific installation of D-amino acid motifs or hydrophobic side-chain perturbations. The protected amino functionality and reactive carboxyl group support assembly of peptide segments that can be ligated or conjugated to biomolecular targets, including engineered protein domains or peptide-based linkers. The D stereocenter and branched isoleucine side chain can be leveraged to alter local structure, reduce proteolysis, and improve stability of engineered constructs used in biochemical research. The compound therefore serves as a building block for generating stereochemically controlled protein-reactive peptides and biomolecule-modifying intermediates.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-D-isoleucine is suitable for pharmaceutical intermediate preparation where protected D-amino acid building blocks are required for the manufacture of peptide-based active ingredients or peptide conjugates. The Fmoc-protected amine supports robust handling during synthesis and allows stepwise deprotection and coupling strategies that align with industrially scalable peptide manufacturing logic. The free carboxylic acid enables conversion into activated forms for controlled amide bond formation, supporting integration into fragment assembly and late-stage peptide construction. The stereochemically defined D-isoleucine residue can be incorporated into manufacturing routes that target consistent stereochemical outcomes for downstream analytical characterization and formulation-oriented processing.

1. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

2. Myotropic activity of allatostatins in tenebrionid beetles

3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

5. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency